October 2019
Antibiotic Resistance: Patients Don't Get It, and We Need to Help
October 18, 2019
Article
Editor-in-Chief Letter
In the October Editor-in-Chief letter, Dr. Jason Gallagher writes about the role clinicians play in helping patients understand antibiotic resistance.
With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases
October 17, 2019
Article
Feature - Emerging & Re-Emerging Infections
Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.
Eosinophils, Fevers, and Diarrhea With a Surprise Diagnosis in a Patient With AIDS
October 16, 2019
Article
Case Study
When the CD4 count seems too good to be true.
"Antibiotic Never Events": The Ideal Target to Reduce Antimicrobial Exposure
October 15, 2019
Article
Stewardship & Prevention
By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.
Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens
October 14, 2019
Article
Multidrug-Resistant Infections
Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.
Rapid ART Initiation: A New Model Presents Unique Opportunities and Challenges
October 11, 2019
Article
HIV / AIDS
Patients with a new diagnosis of HIV may benefit from rapid start of ART.
Investigational Treatments for Clostridioides difficile Infection
October 10, 2019
Article
Acute Infections
The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.
What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
October 09, 2019
Article
News and Breakthroughs
Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.
Where to Treat Uncomplicated HCV? Assessing the Impact of Shifting Care From Specialists to PCPs
October 08, 2019
Article
In the Literature
One promising proposal to greatly increase access to DAA HCV therapy is to keep this treatment with appropriately trained PCPs, in contrast with referring patients to infectious disease, gastroenterology, or hepatology subspecialists.
Same-Day PrEP Initiation: Simplifying Access and Dismantling Barriers to Care
October 07, 2019
Article
In the Literature
Unsurprisingly, STD clinics have reported increased patient interest in PrEP; however, these clinics often face challenges in providing longitudinal patient care because of limited resources and capacity.